Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Mads Nybo"'
Autor:
Daniel Prieto-Alhambra, Danielle E Robinson, Yoav Ben-Shlomo, Fergus Caskey, Mads Nybo, M Sanni Ali, Cyrus Cooper, Muhammad Javaid, Martin Thomsen Ernst, Katrine Hass Rubin, Anne Pernille Hermann, Nigel K Arden, Andrew Judge
Publikováno v:
Archives of Osteoporosis
Ali, M S, Ernst, M, Robinson, D E, Caskey, F, Arden, N K, Ben-Shlomo, Y, Nybo, M, Rubin, K H, Judge, A, Cooper, C, Javaid, M K, Hermann, A P & Prieto-Alhambra, D 2020, ' Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease : an open cohort multivariable and propensity score analysis from Funen, Denmark ', Archives of Osteoporosis, vol. 15, no. 1, 81 . https://doi.org/10.1007/s11657-020-00746-z
Ali, M S, Ernst, M, Robinson, D E, Caskey, F, Arden, N K, Ben-Shlomo, Y, Nybo, M, Rubin, K H, Judge, A, Cooper, C, Javaid, M K, Hermann, A P & Prieto-Alhambra, D 2020, ' Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease : an open cohort multivariable and propensity score analysis from Funen, Denmark ', Archives of Osteoporosis, vol. 15, no. 1, 81 (2020) . https://doi.org/10.1007/s11657-020-00746-z
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Ali, M S, Ernst, M, Robinson, D E, Caskey, F, Arden, N K, Ben-Shlomo, Y, Nybo, M, Rubin, K H, Judge, A, Cooper, C, Javaid, M K, Hermann, A P & Prieto-Alhambra, D 2020, ' Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease : an open cohort multivariable and propensity score analysis from Funen, Denmark ', Archives of Osteoporosis, vol. 15, no. 1, 81 . https://doi.org/10.1007/s11657-020-00746-z
Ali, M S, Ernst, M, Robinson, D E, Caskey, F, Arden, N K, Ben-Shlomo, Y, Nybo, M, Rubin, K H, Judge, A, Cooper, C, Javaid, M K, Hermann, A P & Prieto-Alhambra, D 2020, ' Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease : an open cohort multivariable and propensity score analysis from Funen, Denmark ', Archives of Osteoporosis, vol. 15, no. 1, 81 (2020) . https://doi.org/10.1007/s11657-020-00746-z
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Summary Bisphosphonates are contraindicated in moderate-to-severe chronic kidney disease patients. However, they are used to prevent fragility fractures in patients with impaired kidney function, despite a lack of evidence on their effects on bone de